CTSO

CTSO

Cytosorbents Corporation Common Stock

$1.090+-0.000 (-0.000%)

即時價格

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$1.090

最高

$1.090

最低

$1.090

交易量

0.01M

公司基本面

交易統計

相關新聞

PR Newswire

CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...

查看更多
CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025
Analyst Upgrades

D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target

D. Boral Capital analyst Jason Kolbert maintains CytoSorbents with a Buy and maintains $10 price target.

查看更多
D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target
Analyst Upgrades

HC Wainwright & Co. Reiterates Neutral on CytoSorbents, Maintains $1 Price Target

HC Wainwright & Co. analyst Sean Lee reiterates CytoSorbents with a Neutral and maintains $1 price target.

查看更多
HC Wainwright & Co. Reiterates Neutral on CytoSorbents, Maintains $1 Price Target
PR Newswire

CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...

查看更多
CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update
Analyst Upgrades

D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target

D. Boral Capital analyst Jason Kolbert maintains CytoSorbents with a Buy and maintains $10 price target.

查看更多
D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target